Astellas Donates 25 kg Tacrolimus to U.S. API Reserve Under Pricing Deal
Astellas Pharma is donating 25 kg of tacrolimus active pharmaceutical ingredient to the U.S. Strategic Active Pharmaceutical Ingredients Reserve, a stockpile bolstered by an August 2025 executive order. The donation is paired with Medicaid price concessions in a voluntary pricing agreement with the U.S. government announced Aug. 31.